The global veterinary artificial reproduction market was valued at $1,349.4 million in 2020, and is estimated to reach $2,229.3 million by 2030, growing at a CAGR of 5.30% from 2021 to 2030.
Artificial reproduction is the technique in which semen with living sperms is collected from male and introduced into female reproductive tract at proper time with the help of instruments. This has been found to result in a normal offspring.
The technique has been commercially available for over 60 years and has been utilized very effectively in the cattle and dairy industry. Artificial reproduction can reduce many of the risks involved with animal breeding and disease transmission, which acts as a key factor in the market growth. Increase in productivity using artificial reproduction technology propels the market growth. In addition, female offspring born through artificial reproduction are found to produce more milk than normal offspring. The use of semen extenders containing antibiotics is also helpful in preventing transmission of bacterial diseases.
Furthermore, the entire procedure of reproduction is considered to be much more hygienic than natural mating. Moreover, as production conditions and needs of farmers evolve, many of animal breeds are no longer suitable for majority of farms. However, artificial insemination is used as a preferred reproduction method for such breeds and makes it possible to continue to farm the breeds in-situ.
Rise in human population is also a major factor leading to continuous need for growing animal productivity. Moreover, associated advantages such as increased efficiency of bull usage, genetic selection, decreased cost of housing, handling bull, and safety for farmers and animals are anticipated to increase adoption of artificial insemination during the forecast period. Furthermore, increase in calf prices are also leading to adoption of artificial insemination technology among farmers. According to a report published by the Beef Cattle Research Council in March 2018, bull prices were $ 5,500 to $ 8,000 in Canada from 2015 to 2016. These prices decreased from $ 4,500 to $ 6,500 from 2017 to 2018, owing to the adoption of artificial insemination.
The demand for the genetically superior breed of animals is increasing, which, in turn, is increasing demand for artificial reproduction procedures in animals. Furthermore, the industry players are continuously trying to develop new products, along with partnerships, collaboration, and acquisitions to sustain their market share. For instance, in August 2020, Cogent collaborated with AB Europe, a sheep breeding company, to launch a novel sexed semen service for sheep producers in the U.K. In May 2018, Recombinetics partnered with SEMEX for the implementation of a precision breeding program that improved animal health and well-being through hornless dairy cattle genetics. Moreover, increased adoption of cattle for artificial insemination procedures, rising milk consumption, and production of beef are the key factors responsible for the significant growth of the veterinary artificial reproduction market.
The veterinary artificial reproduction market is segmented on the basis of product, technique, end user, and region. By product, the market is categorized into equipment, reagents & kits, and others. By technique, the market is divided into artificial insemination, in-vitro fertilization (IVF) technology, and others. By end user, it is fragmented into veterinary hospitals, veterinary clinics, and others.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Some of the major companies that operate in the global veterinary artificial reproduction market are Bovine Elite LLC, KRUUSE, Agtech Inc., IMV Technologies, Zoetis Inc., Neogen Corporation, National Meditek, Swine Genetics International, Select Sires Inc., SEMEX.
Artificial reproduction is the technique in which semen with living sperms is collected from male and introduced into female reproductive tract at proper time with the help of instruments. This has been found to result in a normal offspring.
The technique has been commercially available for over 60 years and has been utilized very effectively in the cattle and dairy industry. Artificial reproduction can reduce many of the risks involved with animal breeding and disease transmission, which acts as a key factor in the market growth. Increase in productivity using artificial reproduction technology propels the market growth. In addition, female offspring born through artificial reproduction are found to produce more milk than normal offspring. The use of semen extenders containing antibiotics is also helpful in preventing transmission of bacterial diseases.
Furthermore, the entire procedure of reproduction is considered to be much more hygienic than natural mating. Moreover, as production conditions and needs of farmers evolve, many of animal breeds are no longer suitable for majority of farms. However, artificial insemination is used as a preferred reproduction method for such breeds and makes it possible to continue to farm the breeds in-situ.
Rise in human population is also a major factor leading to continuous need for growing animal productivity. Moreover, associated advantages such as increased efficiency of bull usage, genetic selection, decreased cost of housing, handling bull, and safety for farmers and animals are anticipated to increase adoption of artificial insemination during the forecast period. Furthermore, increase in calf prices are also leading to adoption of artificial insemination technology among farmers. According to a report published by the Beef Cattle Research Council in March 2018, bull prices were $ 5,500 to $ 8,000 in Canada from 2015 to 2016. These prices decreased from $ 4,500 to $ 6,500 from 2017 to 2018, owing to the adoption of artificial insemination.
The demand for the genetically superior breed of animals is increasing, which, in turn, is increasing demand for artificial reproduction procedures in animals. Furthermore, the industry players are continuously trying to develop new products, along with partnerships, collaboration, and acquisitions to sustain their market share. For instance, in August 2020, Cogent collaborated with AB Europe, a sheep breeding company, to launch a novel sexed semen service for sheep producers in the U.K. In May 2018, Recombinetics partnered with SEMEX for the implementation of a precision breeding program that improved animal health and well-being through hornless dairy cattle genetics. Moreover, increased adoption of cattle for artificial insemination procedures, rising milk consumption, and production of beef are the key factors responsible for the significant growth of the veterinary artificial reproduction market.
The veterinary artificial reproduction market is segmented on the basis of product, technique, end user, and region. By product, the market is categorized into equipment, reagents & kits, and others. By technique, the market is divided into artificial insemination, in-vitro fertilization (IVF) technology, and others. By end user, it is fragmented into veterinary hospitals, veterinary clinics, and others.
Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Some of the major companies that operate in the global veterinary artificial reproduction market are Bovine Elite LLC, KRUUSE, Agtech Inc., IMV Technologies, Zoetis Inc., Neogen Corporation, National Meditek, Swine Genetics International, Select Sires Inc., SEMEX.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides an extensive analysis of the current and emerging market trends and dynamics in the global veterinary artificial reproduction market to identify the prevailing opportunities.
- This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
- Comprehensive analysis of factors that drive and restrict the market growth is provided.
- Region-& country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Product
- Equipment
- Reagents and Kits
- Others
By Technique
- Artificial Insemination
- In-Vitro Fertilization (IVF) Technology
- Others
By End User
- Veterinary Hospitals
- Veterinary Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA
KEY MARKET PLAYERS
- Bovine Elite LLC
- KRUUSE
- Agtech Inc.
- IMV Technologies
- Zoetis Inc.
- Neogen Corporation
- National Meditek
- Swine Genetics International
- Select Sires Inc.
- SEMEX
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY PRODUCT
CHAPTER 5: VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY TECHNIQUE
CHAPTER 6: VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY END USER
CHAPTER 7: VETERINARY ARTIFICIAL REPRODUCTION MARKET, BY REGION
List of Tables
List of Figures
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 169 |
| Published | September 2021 |
| Forecast Period | 2020 - 2030 |
| Estimated Market Value ( USD | $ 1349.4 million |
| Forecasted Market Value ( USD | $ 2229.3 million |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
